| Literature DB >> 29435850 |
Eliseo Pascual1,2, Francisca Sivera3, Mariano Andrés4,5.
Abstract
Hyperuricaemia is an independent risk factor for renal function decline. Evidence is emerging that urate-lowering therapy might be beneficial in subjects with renal impairment. We review the association between renal impairment and gout, some of the related pathogenic processes and the possible impact of gout treatment on the progression of renal impairment. Nevertheless, the management of gout is more complex in the presence of chronic kidney disease. The main aim of gout therapy is to fully dissolve the urate crystals, thus curing the disease. Avoidance of attacks-prophylaxis-and their prompt treatment if they occur, along with accurate information to patients, completes the treatment strategy. This article provides a practical guide to managing gout in older patients and in those with renal impairment. We highlight the shortcomings in our current treatment options and strategies.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29435850 DOI: 10.1007/s40266-018-0517-7
Source DB: PubMed Journal: Drugs Aging ISSN: 1170-229X Impact factor: 3.923